Home » Topics » Regulatory » Patents

Patents
RSS

U.K. researchers synthesize new antifungals

Aug. 31, 2021

TroBio Therapeutics presents new compounds for cancer

Aug. 31, 2021

Mindset Pharma patents 5-HT2A receptor agonists

Aug. 31, 2021

Janssen Biotech divulges DHODH inhibitors

Aug. 31, 2021

Gasherbrum Bio presents new GLP-1 receptor agonists

Aug. 30, 2021

Merck & Co. and The Walter and Eliza Hall Institute of Medical Research divulge new antimalarials

Aug. 30, 2021

Mindset Pharma discloses 5-HT2A receptor agonists

Aug. 30, 2021

Bristol Myers Squibb identifies new Toll-like receptor 7 agonists

Aug. 30, 2021

BioTheryX presents PROTACs including casein kinase I isoform alpha degradation inducers

Aug. 27, 2021

Cannabinoid CB1/CB2 receptor partial agonists patented by Research Triangle Institute

Aug. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...